New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 28, 2017 – The FDA approved Promius Pharma’s Impoyz (clobetasol propionate) 0.025% cream, for the treatment of moderate to severe plaque psoriasis in patients 18 years of age and older.
Download PDF
Return to publications
